A detailed history of Stifel Financial Corp transactions in Ardelyx, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 15,266 shares of ARDX stock, worth $103,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,266
Previous 15,207 0.39%
Holding current value
$103,808
Previous $111,000 1.8%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.89 - $9.31 $347 - $549
59 Added 0.39%
15,266 $113,000
Q1 2024

May 13, 2024

SELL
$6.05 - $9.74 $5,705 - $9,184
-943 Reduced 5.84%
15,207 $111,000
Q4 2023

Feb 12, 2024

BUY
$3.29 - $6.64 $3,290 - $6,640
1,000 Added 6.6%
16,150 $100,000
Q1 2023

May 12, 2023

SELL
$2.68 - $4.79 $13,400 - $23,950
-5,000 Reduced 24.81%
15,150 $72,000
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $6,283 - $14,677
5,150 Added 34.33%
20,150 $57,000
Q4 2021

Feb 14, 2022

BUY
$0.86 - $1.7 $12,900 - $25,500
15,000 New
15,000 $17,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $1.05B
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.